Jafron BiomedicalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Jafron BiomedicalLtd has a total shareholder equity of CN¥3.3B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 49.1%. Its total assets and total liabilities are CN¥5.6B and CN¥2.3B respectively. Jafron BiomedicalLtd's EBIT is CN¥933.7M making its interest coverage ratio -95.3. It has cash and short-term investments of CN¥2.7B.
Key information
49.1%
Debt to equity ratio
CN¥1.62b
Debt
| Interest coverage ratio | -95.3x |
| Cash | CN¥2.71b |
| Equity | CN¥3.29b |
| Total liabilities | CN¥2.30b |
| Total assets | CN¥5.59b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300529's short term assets (CN¥3.3B) exceed its short term liabilities (CN¥872.9M).
Long Term Liabilities: 300529's short term assets (CN¥3.3B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: 300529 has more cash than its total debt.
Reducing Debt: 300529's debt to equity ratio has increased from 0% to 49.1% over the past 5 years.
Debt Coverage: 300529's debt is well covered by operating cash flow (74.1%).
Interest Coverage: 300529 earns more interest than it pays, so coverage of interest payments is not a concern.